Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Mereckiene, J."" wg kryterium: Autor


Tytuł:
Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults.
Autorzy:
Humphreys H; Department of Clinical Microbiology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland.
Corcoran M; Department of Clinical Microbiology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland.; Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin Ireland.
Mereckiene J; Health Services Executive - Health Protection Surveillance Centre, Dublin, Ireland.
Cunney R; Department of Clinical Microbiology, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland.; Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin Ireland.; Department of Microbiology, Children's Health Ireland at Temple Street, Dublin, Ireland.
Cotter S; Health Services Executive - Health Protection Surveillance Centre, Dublin, Ireland.
Pokaż więcej
Źródło:
Epidemiology and infection [Epidemiol Infect] 2023 Jan 26, pp. 1-15. Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
Autorzy:
Savulescu C; Epiconcept, Paris, France.
Krizova P; National Institute of Public Health, Prague, Czech Republic.
Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark.
Ladhani S; Public Health England, London, United Kingdom.
Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland.
Levy C; ACTIV, Créteil, France.
Mereckiene J; Health Protection Surveillance Centre Dublin, Ireland.
Knol M; National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Winje BA; Norwegian Institute of Public Health, Oslo, Norway.
Ciruela P; Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
de Miguel S; General Directorate of Public Health Madrid, Spain.
Guevara M; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
MacDonald L; Public Health Scotland, Glasgow, Scotland, UK.
Kozakova J; National Institute of Public Health, Prague, Czech Republic.
Slotved HC; Statens Serum Institut, Copenhagen, Denmark.
Fry NK; Public Health England, London, United Kingdom.
Pekka Nuorti J; National Institute for Health and Welfare, Helsinki, Finland; Tampere University, Tampere, Finland.
Danis K; Santé publique France, the National Public Health Institute, Saint-Maurice, France.
Corcoran M; Temple Street Children's University Hospital, Irish Pneumococcal Reference Laboratory, Dublin, Ireland.
van der Ende A; Academic Medical Centre, National Reference Laboratory for Bacterial Meningitis, Amsterdam, the Netherlands.
Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway.
Munoz-Almagro C; Hospital Sant Joan de Déu, and International University of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Sanz JC; General Directorate of Public Health Madrid, Spain.
Castilla J; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Smith A; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary & MVLS, University of Glasgow, Glasgow, Scotland, UK.
Colzani E; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Hanquet G; Epiconcept, Paris, France; Antwerp university, Antwerp, Belgium. Electronic address: .
Pokaż więcej
Corporate Authors:
SpIDnet VE study group
Źródło:
Vaccine [Vaccine] 2022 Jun 23; Vol. 40 (29), pp. 3963-3974. Date of Electronic Publication: 2022 May 28.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Pneumococcal Infections*/epidemiology
Pneumococcal Infections*/prevention & control
Streptococcus pneumoniae*
Child ; Humans ; Immunization Schedule ; Infant ; Pneumococcal Vaccines ; Serogroup ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł:
Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures.
Autorzy:
Corcoran M; Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland; Department of Clinical Microbiology, Royal College of Sugeons in Ireland, Dublin, Ireland. Electronic address: .
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland.
Cotter S; Health Protection Surveillance Centre, Dublin, Ireland.
Murchan S; Health Protection Surveillance Centre, Dublin, Ireland.
Lo SW; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.
McGee L; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Breiman RF; Department of Global Health, Rollins School Public Health, Emory University, Atlanta, GA, USA.
Cunney R; Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland; Department of Clinical Microbiology, Royal College of Sugeons in Ireland, Dublin, Ireland; Department of Microbiology, Children's Health Ireland at Temple Street, Dublin, Ireland.
Humphreys H; Department of Clinical Microbiology, Royal College of Sugeons in Ireland, Dublin, Ireland; Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
Bentley SD; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.
Gladstone RA; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK; Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, N-0317 Oslo, Norway.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2021 Aug 16; Vol. 39 (35), pp. 5064-5073. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pneumococcal Infections*/epidemiology
Pneumococcal Infections*/prevention & control
Streptococcus pneumoniae*/genetics
Child ; Genomics ; Humans ; Infant ; Ireland/epidemiology ; Pneumococcal Vaccines ; Serogroup ; Serotyping
Czasopismo naukowe
Tytuł:
Invasive Streptococcus pneumoniae Infections and Vaccine Failures in Children in Ireland From the Postvaccine Era From 2007 to 2018.
Autorzy:
Corcoran M; From the Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland.
Cotter S; Health Protection Surveillance Centre, Dublin, Ireland.
Murchan S; Health Protection Surveillance Centre, Dublin, Ireland.
Cunney R; From the Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland.; Department of Microbiology, Children's Health Ireland at Temple Street, Dublin, Ireland.
Humphreys H; Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, Dublin, Ireland.; Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
Pokaż więcej
Źródło:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2020 Apr; Vol. 39 (4), pp. 339-344.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*epidemiology
Pneumococcal Vaccines/*administration & dosage
Adolescent ; Child ; Child, Preschool ; Humans ; Immunization Schedule ; Incidence ; Infant ; Ireland/epidemiology ; Pneumococcal Infections/etiology ; Pneumococcal Infections/prevention & control ; Serogroup ; Streptococcus pneumoniae/classification ; Streptococcus pneumoniae/isolation & purification ; Treatment Failure
Czasopismo naukowe
Tytuł:
Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season.
Autorzy:
Quattrocchi A; Health Protection Surveillance Centre, Dublin, Ireland; European Programme for Intervention Epidemiology Training, Stockholm, Sweden.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland. Electronic address: jolita.mereckiene@hse.ie.
Fitzgerald M; Health Protection Surveillance Centre, Dublin, Ireland.
Cotter S; Health Protection Surveillance Centre, Dublin, Ireland.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2019 Oct 08; Vol. 37 (43), pp. 6390-6396. Date of Electronic Publication: 2019 Sep 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Influenza Vaccines/*administration & dosage
Patient Acceptance of Health Care/*statistics & numerical data
Pertussis Vaccine/*administration & dosage
Vaccination/*statistics & numerical data
Adolescent ; Adult ; Cross-Sectional Studies ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Influenza Vaccines/immunology ; Influenza, Human/prevention & control ; Ireland/epidemiology ; Middle Aged ; Pertussis Vaccine/immunology ; Pregnancy ; Pregnancy Complications, Infectious/prevention & control ; Pregnant Women ; Surveys and Questionnaires ; Whooping Cough/prevention & control ; Young Adult
Czasopismo naukowe
Tytuł:
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.
Autorzy:
Hanquet G; EpiConcept, Paris, France.; Antwerp University, Antwerp, Belgium.
Krizova P; National Institute of Public Health, Prague, Czech Republic.
Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark.
Ladhani SN; Public Health England, London, UK.
Nuorti JP; National Institute for Health and Welfare, Helsinki, Finland.; University of Tampere, Tampere, Finland.
Lepoutre A; Santé publique France, Saint-Maurice, France.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland.
Knol M; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Winje BA; Norwegian Institute of Public Health, Oslo, Norway.
Ciruela P; Public Health Agency of Catalunya, Barcelona, Spain.; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Ordobas M; General Directorate of Public Health, Madrid, Spain.
Guevara M; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK.
Morfeldt E; Public Health Agency of Sweden, Solna, Sweden.
Kozakova J; National Institute of Public Health, Prague, Czech Republic.
Slotved HC; Statens Serum Institut, Copenhagen, Denmark.
Fry NK; Public Health England, London, UK.
Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland.
Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France.
Corcoran M; Irish Pneumococcal Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland.
van der Ende A; Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Centre, Amsterdam, The Netherlands.
Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway.
Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Recerca Pediátrica, Hospital Sant Joan de Deu, Universitat Internacional de Catalunya, Barcelona, Spain.
Latasa P; General Directorate of Public Health, Madrid, Spain.
Castilla J; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK.
Henriques-Normark B; Public Health Agency of Sweden, Solna, Sweden.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Whittaker R; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Savulescu C; EpiConcept, Paris, France.
Pokaż więcej
Corporate Authors:
SpIDnet/I-MOVE+ Pneumo Group
Źródło:
Thorax [Thorax] 2019 May; Vol. 74 (5), pp. 473-482. Date of Electronic Publication: 2018 Oct 24.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Pneumococcal Vaccines/*pharmacology
Streptococcus pneumoniae/*immunology
Vaccination/*methods
Aged ; Europe/epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Retrospective Studies ; Serogroup
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz